1. Brazil Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Raia Drogasil S.A.

Raia Drogasil S.A.

RADL3.SA
Raia Drogasil S.A.BR flagB3 S.A.
17.44
BRL
+0.37
- -
30.49BMarket Cap
Raia Drogasil S.A.
RADL3.SA
(B3 S.A.)

Recent

price

17.44

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2.1
2.92
3.07
3.56
4.21
5.09
6.44
7.56
8.47
10.05
11.47
13.79
17.3
20.43
23.11
26.87
20.07
Revenue per Share
0.09
0.07
0.06
0.06
0.13
0.19
0.26
0.29
0.29
0.44
0.28
0.43
0.59
0.63
0.71
0.79
0.5
Basic EPS, GAAP
-0.05
-0.06
-0.09
0.04
0.04
0.07
0.04
-0.01
-0.01
0.26
0.46
0.4
-0.21
-0.21
0.37
0.06
-0.15
Free Cash Flow per Basic Share
0.03
0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.3
0.97
0.52
0.52
0.52
1.04
1.03
1.03
1.04
1.43
1.43
1.43
1.49
2.41
2.38
2.88
2.85
Book Value per Share
0.56
1.15
0.62
0.67
0.76
0.85
1.01
1.18
1.33
1.62
1.81
1.85
2.18
2.47
2.63
3.21
3.2
Tangible Book Value per Share
953
935
1,752
1,752
1,747
1,747
1,749
1,749
1,747
1,747
1,749
1,750
1,681
1,663
1,682
1,647
1,669
Basic Weighted Avg Shares
2,005
2,729
5,381
6,233
7,351
8,898
11,257
13,213
14,801
17,566
20,067
24,127
29,067
33,974
38,872
44,250
33,503
Sales/Revenue/Turnover
5.6
2.92
2.99
2.4
4.66
5.63
6.27
6
5.18
5.07
4.46
5.69
6.42
5.75
6.1
5.99
5.78
Operating Margin (%)
31
56
124
159
188
228
274
338
414
1,041
1,177
1,327
700
798
912
1,049
599
Depreciation Expense
89
69
105
101
221
340
448
511
502
772
484
752
996
1,055
1,200
1,297
838
Net Income, GAAP
26.33
24.68
33.67
27.55
26.75
22.05
24.19
25.33
20.28
- -
19.6
22.6
14.94
10.65
14.63
10.21
1.1
Effective Tax Rate (%)
4.44
2.52
1.95
1.62
3.01
3.82
3.98
3.87
3.39
4.4
2.41
3.12
3.43
3.11
3.09
2.93
2.5
Profit Margin (%)
379
835
831
884
969
1,037
1,243
1,434
1,616
1,678
2,219
1,823
3,210
3,482
3,509
4,711
4,901
Working Capital
28
112
131
161
184
188
281
415
570
3,516
4,050
3,865
5,112
5,604
6,130
7,305
7,251
LT Debt
599
2,201
2,265
2,327
2,457
2,657
2,936
3,250
3,535
4,076
4,426
4,719
5,403
6,028
6,447
7,336
7,340
Total Equity
10.92
3.68
4.33
4.22
9.27
13.51
16.6
15.93
14.46
- -
7.94
10.8
14.64
13.93
14.5
15.34
12.37
Return on Invested Capital (%)
17.81
9.54
10.6
10.14
20.43
22.15
22.29
23.86
21.12
- -
9.67
12.81
17.78
17.02
16.46
17.77
13.55
Return on Capital (%)
31.19
11.51
11.54
11.11
24.36
25.04
24.75
28.26
27.78
35.85
19.38
30.08
39.84
32.46
30
29.64
19.03
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
1,529
1,443
LT Borrowings
- -
3,360
3,236
LT Finance Leases
- -
3,945
4,015
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,747
1,782
1,749
Market Capitalization
30,938
39,387
39,272

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
14,904
15,357
Cash, Cash Equivalents & STI
- -
529
538
Accounts Receivable, Net
- -
3,401
2,835
Inventories
- -
9,576
8,440
Total Current Liabilities
- -
10,194
10,456
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,529
1,443
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.73%
10.68%
13.79%
Free Cash Flow
-294.33%
-106.26%
-83.07%
Net Income, GAAP
17.59%
23.08%
8.08%
Sales/Revenue/Turnover
17.47%
17.17%
13.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9,100
9,687
9,989
10,088
38,872
2025
9,273
10,831
- -
12,103
44,250
2026
10,569
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.19
0.2
- -
0.71
2025
0.1
0.22
- -
- -
0.79
2026
0.1
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Nu Skin Enterprises, Inc. (NUS)
Somnigroup International Inc (SGI)
Warpaint London PLC (W7L.L)
Reckitt Benckiser Group plc (RBGLY)
Sunlight (1977) Holdings Limited (8451.HK)
Ming Fai International Holdings Limited (3828.HK)
Business
Raia Drogasil SA (RADL3.SA) operates as Brazil's largest drugstore chain, retailing a broad range of pharmaceutical products, health and beauty items, personal care goods, household essentials, and over-the-counter medications through its Raia and Drogasil banners. The company offers prescription drugs, generic medicines, cosmetics from leading brands, baby products, hygiene supplies, and convenience items such as snacks and beverages; it also provides pharmacy services including vaccinations, blood pressure checks, and medication delivery via its RD app and website. Headquartered in Sao Paulo, Brazil, and founded in 2011 through the merger of Raia SA and Drogasil SA, Raia Drogasil conducts operations exclusively within Brazil, with over 2,800 stores across all regions of the country as of late 2024. In recent developments, the company expanded its store network by opening more than 200 new locations in 2024, strengthening its market leadership in the competitive retail pharmacy sector; it also enhanced its digital ecosystem with upgraded e-commerce capabilities and same-day delivery partnerships in major urban centers. Additionally, Raia Drogasil announced a strategic alliance with select health tech firms in early 2025 to integrate telehealth consultations within its stores, alongside a major funding initiative via a secondary share offering to support accelerated growth amid rising consumer demand for integrated health services. The firm targets middle- and upper-income consumers, families, and chronic disease patients, operating within the retail pharmacy and health & wellness segments without notable subsidiaries or parent entities.